Skip to main content
. 2021 Jun 16;7(2):20552173211025312. doi: 10.1177/20552173211025312

Table 2.

Differences between women with MS who became pregnant or not after MS diagnosis.

Analysis variables
Pregnancy after MS diagnosis
p-value
Yes (n = 82) No (n = 346)
Motherhood before MS diagnosis, n (%) 28 (34.1%) 152 (43.9%) 0.11
Maternity desire after MS diagnosis, n (%) Unchanged 65 (79.3%) 173 (50%) <0.01
Uncertain 5 (6.1%) 70 (20.2%)
Changed 12 (14.6%) 103 (29.8%)
Frequency of neurologist addressing family planning, n (%) Never 22 (26.8%) 161 (46.5%) 0.01
Occasionally 15 (18.3%) 56 (16.2%)
Only at the patient’s request 39 (47.6%) 108 (31.2%)
On every consultation 6 (7.3%) 21 (6.1%)
Neurologist explained about risks related to DMTs and pregnancy, n (%) Yes 54 (65.9%) 146 (42.2%) <0.01
No 28 (34.1%) 200 (57.8%)
Most common information source on MS treatments and pregnancy, n (%)a Uncertain, none or informal 19 (23.2%) 168 (48.6%) <0.01
Formal 63 (76.8%) 178 (51.4%)

aInformal: relatives or friends, internet, other MS patients. Formal: physicians or patients’ organizations. DMTs: Drugs modified treatment.Bold numbers mark the degree of significance.